<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00178659</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-04-040</org_study_id>
    <secondary_id>N-13-04-040</secondary_id>
    <nct_id>NCT00178659</nct_id>
  </id_info>
  <brief_title>Proteomics of Brain Trauma-associated Elevated Intracranial Pressure (ICP)</brief_title>
  <acronym>Proteomics</acronym>
  <official_title>Proteomics of Brain Trauma-associated Elevated Intracranial Pressure (ICP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TIRR/Mission Connect</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Center for Clinical and Translational Sciences (CCTS) Clinical Research Unit at The University of Texas Health Science Center at Houston</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The specific aim of this research is to determine if the blood from brain-injured patients&#xD;
      contains reproducible protein markers that appear prior to elevations in intracranial&#xD;
      pressure (ICP).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the major causes of death following brain trauma is increased intracranial pressure&#xD;
      (ICP). Currently, there are no effective ways to predict if the ICP of a patient will reach&#xD;
      uncontrollable levels. Various cytokines (balance between pro-and anti-inflammatory) and&#xD;
      other factors are thought to underlie increases in ICP. The specific aim of this research is&#xD;
      to determine if the blood from brain-injured patients contains reproducible protein markers&#xD;
      that appear prior to elevations in ICP. We propose to employ mass spectrometry, antibody&#xD;
      array and ELISA to profile proteins in the serum of patients suffering from traumatic brain&#xD;
      injury. These protein profiles will be compiled by a pattern recognition program that has the&#xD;
      capacity to learn and make predictions based on the spectra and associated patient&#xD;
      information. Each time a sample is analyzed, it is added to the database allowing the program&#xD;
      to make increasingly accurate predictions. Protein profiles of patients with known ICP values&#xD;
      will be analyzed. Our hypothesis is that alterations in serum protein composition will&#xD;
      precede changes in intracranial pressure giving rise to predictable patterns that can be&#xD;
      detected using large-scale proteomic analysis. After approximately 90 non-brain trauma and 90&#xD;
      brain-trauma patients are analyzed, if markers are found, the predictability of elevated ICP&#xD;
      will be tested. If successful, this may aid the neurosurgeon in determining future courses of&#xD;
      treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2004</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Elevated intracranial pressure</measure>
    <time_frame>within the first 10 days post injury</time_frame>
    <description>Intracranial pressure &gt;20mmHg</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Brain Injuries, Traumatic</condition>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>1 healthy volunteers</arm_group_label>
    <description>Healthy volunteers to act as controls - Recruitment is complete for this cohort</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 head trauma</arm_group_label>
    <description>Head trauma patients meeting enrollment criteria - Recruitment is complete for this cohort</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 orthopedic injury</arm_group_label>
    <description>The orthopedic injury cohort will include patients admitted to the ED able to provide informed consent with the following:&#xD;
Fracture confirmed radiographically&#xD;
No head trauma&#xD;
No other known inflammatory process or infection&#xD;
No history of neurological or psychiatric disorders or alcohol or drug dependency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4 Mild TBI</arm_group_label>
    <description>The mild TBI patients will be defined as those admitted to the ED experiencing, - Recruitment is complete for this cohort&#xD;
Non-penetrating head trauma manifesting one or more of the following:&#xD;
Loss of consciousness&#xD;
Post-traumatic amnesia&#xD;
Altered mental status&#xD;
Focal neurologic deficits, seizure&#xD;
GCS&gt; 12&#xD;
No abnormalities on CT other than contusion&#xD;
No operative Lesions&#xD;
Length of hospital stay &lt; 48 hrs&#xD;
No other known inflammatory process or infection&#xD;
No history of neurological or psychiatric disorders or alcohol or drug dependency</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood/saliva samples for protein/molecular analysis</intervention_name>
    <description>Bloods samples - healthy volunteers(1 time) head injury subjects (5 times). Blood and/or saliva samples mild TBI patients (2 times) and healthy volunteers (2 times)</description>
    <arm_group_label>1 healthy volunteers</arm_group_label>
    <arm_group_label>2 head trauma</arm_group_label>
    <arm_group_label>3 orthopedic injury</arm_group_label>
    <arm_group_label>4 Mild TBI</arm_group_label>
    <other_name>blood samples</other_name>
    <other_name>saliva samples</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and serum samples for use in identifying proteins related to head trauma&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Consenting healthy volunteers, head trauma, mild head trauma or acute orthopedic injury&#xD;
        patients meeting enrollment criteria listed below.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  14-65 years old&#xD;
&#xD;
          -  Non-penetrating brain injury&#xD;
&#xD;
          -  ICP monitor or&#xD;
&#xD;
          -  Healthy volunteer or&#xD;
&#xD;
        The orthopedic injury cohort will include patients admitted to the ED able to provide&#xD;
        informed consent with the following:&#xD;
&#xD;
          1. Fracture confirmed radiographically&#xD;
&#xD;
          2. No head trauma&#xD;
&#xD;
          3. No other known inflammatory process or infection&#xD;
&#xD;
          4. No history of neurological or psychiatric disorders or alcohol or drug dependency.&#xD;
&#xD;
        or The mild TBI patients will be defined as those experiencing,&#xD;
&#xD;
          1. Non-penetrating head trauma manifesting one or more of the following:&#xD;
&#xD;
               -  Loss of consciousness&#xD;
&#xD;
               -  Post-traumatic amnesia&#xD;
&#xD;
               -  Altered mental status&#xD;
&#xD;
               -  Focal neurologic deficits, seizure&#xD;
&#xD;
          2. GCS&gt; 12&#xD;
&#xD;
          3. No abnormalities on CT other than contusion&#xD;
&#xD;
          4. No operative Lesions&#xD;
&#xD;
          5. Length of hospital stay &lt; 48 hrs&#xD;
&#xD;
          6. No other known inflammatory process or infection&#xD;
&#xD;
          7. No history of neurological or psychiatric disorders or alcohol or drug dependency&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to obtain informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pramod Dash, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas, Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The University of Texas, Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Redell JB, Moore AN, Ward NH 3rd, Hergenroeder GW, Dash PK. Human traumatic brain injury alters plasma microRNA levels. J Neurotrauma. 2010 Dec;27(12):2147-56. doi: 10.1089/neu.2010.1481. Epub 2010 Nov 23.</citation>
    <PMID>20883153</PMID>
  </reference>
  <reference>
    <citation>Hergenroeder GW, Moore AN, McCoy JP Jr, Samsel L, Ward NH 3rd, Clifton GL, Dash PK. Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation. 2010 Mar 11;7:19. doi: 10.1186/1742-2094-7-19.</citation>
    <PMID>20222971</PMID>
  </reference>
  <reference>
    <citation>Hergenroeder G, Redell JB, Moore AN, Dubinsky WP, Funk RT, Crommett J, Clifton GL, Levine R, Valadka A, Dash PK. Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure. J Neurotrauma. 2008 Feb;25(2):79-93. doi: 10.1089/neu.2007.0386.</citation>
    <PMID>18260791</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>September 3, 2021</last_update_submitted>
  <last_update_submitted_qc>September 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Georgene Hergenroeder</investigator_full_name>
    <investigator_title>Associate Professor, Neurosurgery</investigator_title>
  </responsible_party>
  <keyword>Traumatic Brain Injury</keyword>
  <keyword>TBI (Traumatic Brain Injury)</keyword>
  <keyword>Proteomics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Intracranial Hypertension</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make individual participant data available</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

